149
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Total Psoas Area Index is Valuable to Assess Sarcopenia, Sarcopenic Overweight/Obesity and Predict Outcomes in Patients Undergoing Open Pancreatoduodenectomy

ORCID Icon, , , &
Pages 761-770 | Published online: 09 Jul 2020

References

  • Witkowski ER, Smith JK, Tseng JF. Outcomes following resection of pancreatic cancer. J Surg Oncol. 2013;107(1):97–103. doi:10.1002/jso.2326722991309
  • Peng P, Hyder O, Firoozmand A, et al. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg. 2012;16(8):1478–1486. doi:10.1007/s11605-012-1923-522692586
  • Martin D, Joliat GR, Halkic N, Demartines N, Schäfer M. Perioperative nutritional management of patients undergoing pancreatoduodenectomy: an international survey among surgeons. HPB (Oxford). 2020;22(1):75–82. doi:10.1016/j.hpb.2019.05.00931257012
  • Gianotti L, Sandini M. The 2019 ESPEN arvid wretlind lecture perioperative nutritional and metabolic care: patient-tailored or organ-specific approach? Clin Nutr. 2019;S0261-5614(19)33122-X. doi:10.1016/j.clnu.2019.10.029
  • Englesbe MJ, Terjimanian MN, Lee JS, et al. Morphometric age and surgical risk. J Am Coll Surg. 2013;216(5):976–985. doi:10.1016/j.jamcollsurg.2013.01.05223522786
  • Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing. 2010;39(4):412–423. doi:10.1093/ageing/afq03420392703
  • Namm JP, Thakrar KH, Wang CH, et al. A semi-automated assessment of sarcopenia using psoas area and density predicts outcomes after pancreaticoduodenectomy for pancreatic malignancy. J Gastrointest Oncol. 2017;8(6):936–944. doi:10.21037/jgo.2017.08.0929299352
  • Sandini M, Bernasconi DP, Fior D, et al. A high visceral adipose tissue-to-skeletal muscle ratio as a determinant of major complications after pancreatoduodenectomy for cancer. Nutrition. 2016;32(11–12):1231–1237. doi:10.1016/j.nut.2016.04.00227261062
  • Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res. 2009;15(22):6973–6979. doi:10.1158/1078-0432.CCR-09-152519887488
  • Gianotti L, Besselink MG, Sandini M, et al. Nutritional support and therapy in pancreatic surgery: a position paper of the international study group on pancreatic surgery (ISGPS). Surgery. 2018;164(5):1035–1048. doi:10.1016/j.surg.2018.05.04030029989
  • Donini LM, Busetto L, Bauer JM, et al. Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review. Clin Nutr. 2019:S0261-5614(19)33151–6. doi:10.1016/j.clnu.2019.11.024.
  • Onesti JK, Wright GP, Kenning SE, et al. Sarcopenia and survival in patients undergoing pancreatic resection. Pancreatology. 2016;16(2):284–289. doi:10.1016/j.pan.2016.01.00926876798
  • Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33(5):997–1006. doi:10.1139/H08-07518923576
  • Yamashita M, Kamiya K, Matsunaga A, et al. Prognostic value of psoas muscle area and density in patients who undergo cardiovascular surgery. Can J Cardiol. 2017;33:1652–1659. doi:10.1016/j.cjca.2017.10.00929173605
  • Chang JS, Kim TH, Kim H, Choi EH, Kim N, Kong ID. Qualitative muscle mass index as a predictor of skeletal muscle function deficit in Asian older adults. Geriatr Gerontol Int. 2017;17(1):99–107. doi:10.1111/ggi.1268126711225
  • Yang ZX, Zhao WH, Zhai Y, Chen CM. Prediction on the prevalence of obesity by mean value of body mass index of population. Chin J Epidemiol. 2006;27:566–569.
  • Kondrup J, Alison SP, Elia M, Vellas B, Plauth M. Educational and clinical practice committee, European society of parenteral and enteral nutrition (ESPEN). ESPEN guidelines for nutrition screening 2002. Clin Nutr. 2003;2(4):415–421. doi:10.1016/S0261-5614(03)00098-0
  • Cederholm T, Jensen GL, Correia MITD, et al. GLIM criteria for the diagnosis of malnutrition - a consensus report from the global clinical nutrition community. Clin Nutr. 2019;38(1):1–9. doi:10.1016/j.clnu.2018.08.00230181091
  • Xu JY, Zhang AR, Tang BJ, et al. Modification of a new subclassification of grade B postoperative pancreatic fistula: a bicenter retrospective cohort study. J Hepatobiliary Pancreat Sci. 2020. doi:10.1002/jhbp.780
  • Braga M, Ljungqvist O, Soeters P, Fearon K, Weimann A, Bozzetti F. ESPEN. ESPEN guidelines on parenteral nutrition: surgery. Clin Nutr. 2009;28(4):378–386. doi:10.1016/j.clnu.2009.04.00219464088
  • Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–213. doi:10.1097/01.sla.0000133083.54934.ae15273542
  • Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the international study group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery. 2017;161(3):584–591. doi:10.1016/j.surg.2016.11.01428040257
  • Xu JY, Zhu MW, Zhang H, et al. A cross-sectional study of GLIM-defined malnutrition based on new validated calf circumference cut-off values and different screening tools in hospitalized patients over 70 years old. J Nutr Health Aging. 2020. doi:10.1007/s12603-020-1386-4
  • Vallance AE, Young AL, Macutkiewicz C, Roberts KJ, Smith AM. Calculating the risk of a pancreatic fistula after a pancreaticoduodenectomy: a systematic review. HPB (Oxford). 2015;17(11):1040–1048. doi:10.1111/hpb.1250326456948
  • Winter JM, Cameron JL, Campbell KA, et al. Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg. 2006;10(9):1280–1290. doi:10.1016/j.gassur.2006.07.02017114014
  • Kakita A, Yoshida M, Takahashi T. History of pancreaticojejunostomy in pancreaticoduodenectomy: development of a more reliable anastomosis technique. J Hepatobiliary Pancreat Surg. 2001;8(3):230–237. doi:10.1007/s00534017002211455485
  • Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle. 2016;7(5):512–514. doi:10.1002/jcsm.1214727891296
  • Di Sebastiano KM, Yang L, Zbuk K, et al. Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia. Br J Nutr. 2013;28(109):302–312. doi:10.1017/S0007114512001067
  • Nishida Y, Kato Y, Kudo M, et al. Preoperative sarcopenia strongly influences the risk of postoperative pancreatic fistula formation after pancreaticoduodenectomy. J Gastrointest Surg. 2016;20(9):1586–1594. doi:10.1007/s11605-016-3146-727126054
  • Pecorelli N, Carrara G, De Cobelli F, et al. Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery. Br J Surg. 2016;103(4):434–442. doi:10.1002/bjs.1006326780231
  • Dent E, Morley JE, Cruz-Jentoft AJ, et al. International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management. J Nutr Health Aging. 2018;22(10):1148–1161. doi:10.1007/s12603-018-1139-930498820
  • Yoshida D, Shimada H, Park H, et al. Development of an equation for estimating appendicular skeletal muscle mass in Japanese older adults using bioelectrical impedance analysis. Geriatr Gerontol Int. 2014;14(4):851–857. doi:10.1111/ggi.1217724450604
  • Takagi K, Yoshida R, Yagi T, et al. Radiographic sarcopenia predicts postoperative infectious complications in patients undergoing pancreaticoduodenectomy. BMC Surg. 2017;17(1):64. doi:10.1186/s12893-017-0261-728549466
  • Ratnayake CB, Loveday BP, Shrikhande SV, Windsor JA, Pandanaboyana S. Impact of preoperative sarcopenia on postoperative outcomes following pancreatic resection: a systematic review and meta-analysis. Pancreatology. 2018;18(8):996–1004. doi:10.1016/j.pan.2018.09.01130287167
  • Dodson RM, Firoozmand A, Hyder O, et al. Impact of sarcopenia on outcomes following intra-arterial therapy of hepatic malignancies. J Gastrointest Surg. 2013;17(12):2123–2132. doi:10.1007/s11605-013-2348-524065364
  • Psutka SP, Carrasco A, Schmit GD, et al. Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality. Cancer. 2014;120(18):2910–2918. doi:10.1002/cncr.2879824840856
  • Durand F, Buyse S, Francoz C, et al. Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography. J Hepatol. 2014;60(6):1151–1157. doi:10.1016/j.jhep.2014.02.02624607622
  • Aubrey J, Esfandiari N, Baracos VE, et al. Measurement of skeletal muscle radiation attenuation and basis of its biological variation. Acta Physiol (Oxf). 2014;210(3):489–497. doi:10.1111/apha.1222424393306
  • Hamaguchi Y, Kaido T, Okumura S, et al. Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults. Nutrition. 2016;32(11–12):1200–1205. doi:10.1016/j.nut.2016.04.00327292773
  • Muscaritoli M, Anker SD, Argilés J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups(SIG) “cachexiaanorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr. 2010;29(2):154. doi:10.1016/j.clnu.2009.12.00420060626
  • Okumura S, Kaido T, Hamaguchi Y, et al. Visceral adiposity and sarcopenic visceral obesity are associated with poor prognosis after resection of pancreatic cancer. Ann Surg Oncol. 2017;24(12):3732–3740. doi:10.1245/s10434-017-6077-y28871520
  • Sur MD, Namm JP, Hemmerich JA, Buschmann MM, Roggin KK, Dale W. Radiographic sarcopenia and self-reported exhaustion independently predict NSQIP serious complications after pancreaticoduodenectomy in older adults. Ann Surg Oncol. 2015;22(12):3897–3904. doi:10.1245/s10434-015-4763-126242367
  • Stretch C, Aubin JM, Mickiewicz B, et al. Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas. PLoS One. 2018;13(5):e0196235. doi:10.1371/journal.pone.019623529723245